113 related articles for article (PubMed ID: 38741404)
1. Biopolymeric nanoencapsulation of model drug: Its development and characterisation.
Kumar S; Venkata N; Madhav S; Pandey S
Pak J Pharm Sci; 2024 Jan; 37(1):85-94. PubMed ID: 38741404
[TBL] [Abstract][Full Text] [Related]
2. Exploration of Inbuilt Novel Properties as Bioretardant Cum Stabilizer of Isolated Biopolymer from
Kumar S; Madhav NVS
Iran J Pharm Res; 2021; 20(3):78-93. PubMed ID: 34903971
[TBL] [Abstract][Full Text] [Related]
3. Formulation of spray-dried phenytoin loaded poly(epsilon-caprolactone) microcarrier intended for brain delivery to treat epilepsy.
Li Z; Li Q; Simon S; Guven N; Borges K; Youan BB
J Pharm Sci; 2007 May; 96(5):1018-30. PubMed ID: 17455322
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity.
Kırımlıoğlu GY; Özer S; Büyükköroğlu G; Yazan Y
Comb Chem High Throughput Screen; 2021; 24(3):328-341. PubMed ID: 32342810
[TBL] [Abstract][Full Text] [Related]
5. Reconstituted spray-dried phenytoin-loaded nanocapsules improve the in vivo phenytoin anticonvulsant effect and the survival time in mice.
de Oliveira EG; Cardoso AM; Paese K; Coradini K; de Oliveira CV; Pohlmann AR; Oliveira MS; Guterres SS; Beck RCR
Int J Pharm; 2018 Nov; 551(1-2):121-132. PubMed ID: 30218826
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, colloidal properties and cytotoxicity of biopolymer nanoparticles.
Moorkoth D; Nampoothiri KM
Appl Biochem Biotechnol; 2014 Nov; 174(6):2181-94. PubMed ID: 25172058
[TBL] [Abstract][Full Text] [Related]
7. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
8. Phenytoin-loaded lipid-core nanocapsules improve the technological properties and in vivo performance of fluidised bed granules.
de Oliveira EG; de Oliveira RS; Zatta KC; Furian AF; Oliveira MS; Pohlmann AR; Guterres SS; Beck RCR
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110753. PubMed ID: 32279762
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterisation of phenytoin-loaded alginate and alginate-chitosan microparticles.
Cekić ND; Savić SD; Milić J; Savić MM; Jović Z; Malesević M
Drug Deliv; 2007 Nov; 14(8):483-90. PubMed ID: 18027177
[TBL] [Abstract][Full Text] [Related]
10. Inbuilt novel bioretardant feature of biopolymer isolated from
Tyagi Y; Madhav NS
J Drug Assess; 2020; 9(1):72-81. PubMed ID: 32341840
[No Abstract] [Full Text] [Related]
11. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS).
Atef E; Belmonte AA
Eur J Pharm Sci; 2008 Nov; 35(4):257-63. PubMed ID: 18706499
[TBL] [Abstract][Full Text] [Related]
12. Topical phenytoin nanostructured lipid carriers: design and development.
Motawea A; Borg T; Abd El-Gawad AEH
Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451
[TBL] [Abstract][Full Text] [Related]
13. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
[TBL] [Abstract][Full Text] [Related]
14. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
Zafar A
J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
[TBL] [Abstract][Full Text] [Related]
15. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
16. Formulation of acyclovir-loaded solid lipid nanoparticles: design, optimization, and
El-Gizawy SA; El-Maghraby GM; Hedaya AA
Pharm Dev Technol; 2019 Dec; 24(10):1287-1298. PubMed ID: 31507232
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine encapsulated intra-nasal nanoliposome formulation for epilepsy treatment: Formulation design, characterization and nasal toxicity study.
Praveen A; Aqil M; Imam SS; Ahad A; Moolakkadath T; Ahmad FJ
Colloids Surf B Biointerfaces; 2019 Feb; 174():553-562. PubMed ID: 30502666
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA
Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680
[TBL] [Abstract][Full Text] [Related]
19. pH-sensitive chitosan nanoparticles loaded with dolutegravir as milk and food admixture for paediatric anti-HIV therapy.
Priya Dharshini K; Fang H; Ramya Devi D; Yang JX; Luo RH; Zheng YT; Brzeziński M; Vedha Hari BN
Carbohydr Polym; 2021 Mar; 256():117440. PubMed ID: 33483020
[TBL] [Abstract][Full Text] [Related]
20. Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In vitro and rat in vivo studies.
El-Zaafarany GM; Soliman ME; Mansour S; Awad GA
Int J Pharm; 2016 Apr; 503(1-2):127-40. PubMed ID: 26924357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
